Pasithea Therapeutics Corp. (KTTA) NASDAQ
0.77
+0.0259(+3.48%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 9.07M |
| Enterprise Value | -55.15B |
| P/E Ratio | -0 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 2,741.01 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.34 |
| Return On Equity | -1.48 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -20.86B |
| Net Income | -20.43B |
| Diluted EPS | -2.91 |
Balance Sheet
| Total Cash | 55.16B |
| Total Cash/Share | 7,845.11 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 11.35 |
| Book Value Per Share | 7,853.68 |
Price History
| 52-Week Change | -35.3 |
| 52-Week High | 3.79 |
| 52-Week Low | 0.28 |
| Moving Average 50 Days | 0.8 |
| Moving Average 200 Days | 0.81 |
Statistics
| Average Volume | 285,390 |
| Shares Outstanding | 7.44M |
| % Held by Institutions | 173.64 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | January 02, 2024 |
